SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer

NCT06266871 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
64
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

West China Hospital